Plasma soluble urokinase plasminogen activator receptor (suPAR) and Scr are capable of specifically distinguishing critically ill children who are at a high risk of developing non-septic AKI and sepsis-associated AKI [244]. The gene discussed is PLAUR; the disease is Sepsis.